Cost-effectiveness analysis of maintenance agonist treatments in the NEPOD

References

• United Nations International Drug Control Programme (UNIDCP). World Drug Report. Oxford University Press, NY, USA (2001).
   Google Scholar
• World Health Organisation. World Health Report 2002: Reducing Risks And Promoting Healthy Life. World Health Organisation, Geneva, Switzerland (2002).
   Google Scholar
• Mathers CD, Vos ET, Stevenson CE, Begg SJ. The burden of disease and injury in Australia. Bulletin WHO79, 1076–1084 (2001).
   PubMed Web of Science ®Google Scholar
• Hall W, Ross J, Lynskey M, Law M, Degenhardt L. How many dependent opioid users are there in Australia? In: National Drug and Alcohol Research Centre Monograph Series 44. National Drug and Alcohol Research Centre, Sydney, Australia (2000).
   Google Scholar
• National Drug Strategy Household Survey – First Results. Drug Statistics Series No. 13. Australian Institute of Health and Welfare. (AIHW), Canberra, Australia AIHW Cat. No. PHE 57 (2005).
   Google Scholar
• Vlahov D, Wang C, Galai N. Mortality risk among new onset injection drug users. Addiction99, 946–954 (2004).
   PubMed Web of Science ®Google Scholar
• Darke S, Ross J. Suicide among heroin users: rates, risk factors and methods. Addiction97, 1383–1394 (2002).
   PubMed Web of Science ®Google Scholar
• Ball JC, Shaffer JW, Nurco DN. The day-to-day criminality of heroin addicts in Baltimore: a study in the continuity of offence rates. Drug Alcohol Depend.12, 119–142 (1983).
   PubMed Web of Science ®Google Scholar
• Digiusto E, Shakeshaft A, Mattick RP, NEPOD Research Group. Effects of Pharmacotherapies for Opioid Dependence on Participants' Criminal Behaviour and Expenditure on Illicit Drugs: an Australian National Evaluation (NEPOD). Australian NZ J Criminology.(2006).
   Google Scholar
• Ball JC, Ross A. The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services and Outcomes. Springer-Verlag, NY, USA (1991).
   Google Scholar
• Hall W, Bell J, Carless J. Crime and drug use among applicants for methadone maintenance. Drug Alcohol Depend.31, 123–129 (1993).
   PubMed Web of Science ®Google Scholar
• UNDCP. Economic and Social Consequences of Drug Abuse and Illicit Trafficking. United Nations Drug Control Program Vienna, Austria (1998).
   Google Scholar
• Collins DJ, Lapsley H. Counting the cost: estimates of the social costs of drug abuse in Australia in 1998–99. National Drug Strategy Monograph Series No. 49. Canberra, Commonwealth of Australia (2002).
   Google Scholar
• Amato L, Davoli M, Perucci CA, Ferri M, Faggiano F, Mattick RP. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J. Subst. Abuse Treat.28, 321–329 (2005).
   PubMed Web of Science ®Google Scholar
• Drummond MF, O'Brien B, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Porgrammes. Oxford University Press, Oxford, UK (1987).
   Google Scholar
• Doran CM, Shanahan M, Mattick RP, Ali R, White J, Bell J. Buprenorphine versus methadone maintenance: a cost-effectiveness analysis. Drug Alcohol Depend.71, 295–302 (2003).
   PubMed Web of Science ®Google Scholar
• Barnett PG. The cost-effectiveness of methadone maintenance as a health care intervention. Addiction94, 479–488 (1999).
   PubMed Web of Science ®Google Scholar
• Barnett PG, Zaric GS, Brandeau ML. The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States. Addiction96, 1267–1278 (2001).
   PubMed Web of Science ®Google Scholar
• Zaric GS, Barnett PG, Brandeau ML. HIV transmission and the cost-effectiveness of methadone maintenance. Am. J. Public Health90, 1100–1111 (2000).
   PubMed Web of Science ®Google Scholar
• Cartwright WS. Cost-benefit Analysis of drug treatment services: review of the literature. J. Mental Health Policy Econ.3, 11–26 (2000).
   PubMedGoogle Scholar
• Mattick RP, Digiusto E, Doran CMet al. National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Commonwealth Department of Health and Ageing, Canberra, Australia (2001).
   Google Scholar
• Digiusto E, Mattick RP, Kimber Jet al. National Evaluation of Pharmacotherapies for Opioid Dependence –Why have we done it? Drug Alcohol Rev.20, 139–141 (2001).
   Google Scholar
• Shanahan MD, Doran CM, Digiusto Eet al. A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD). Addict. Behav.,31(3), 371–387 (2006).
   PubMed Web of Science ®Google Scholar
• Mattick RP, Ali R, White J, O'Brien S, Wolk S, Danz C. Buprenorphine versus methadone maintenance treatment: a randomised double-blind trial with 405 opioid dependant patients. Addiction98, 441–452 (2003).
   PubMed Web of Science ®Google Scholar
• Lintzeris N, Ritter A, Panjari M, Clark N, Kutin J, Bammer G. Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial. Am. J. Addictions13, S29–S41 (2004).
   PubMed Web of Science ®Google Scholar
• Harris AH, Gospodarevskaya E, Ritter A. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting. Pharmacoeconomics23, 77–91 (2005).
   PubMed Web of Science ®Google Scholar
• Ritter A, Lintzeris N, Clark N, Panjari M, Kutin J, Bammer G. A randomised trial comparing levo-alpha acetylmethadol with methadone maintenance for patients in primary care settings in Australia. Addiction98, 1065–1113 (2003).
   Google Scholar
• Ward J, Mattick RP, Hall W. Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Harwood Press, London, UK (1998)
   Google Scholar
• Commonwealth Department of Health and Family Services. Medicare Benefits Schedule. Australian Government Publishing Service, Canberra, Australia (2001).
   Google Scholar
• Commonwealth of Australia. Schedule of Pharmaceutical Benefits For Approved Pharmacists and Medical Practitioners, Australian Government Publishing Service, Canberra, Australia (2005).
   Google Scholar
• MediMedia. MIMS Annual 2001. MediMedia, St Leonards, Australia (2001).
   Google Scholar
• Australian Bureau of Statistics. Consumer Price Index. Cat. No. 6401. ABS Canberra, Australia (2001).
   Google Scholar
• British Medical Association. British National Formulary. British Medical Association and the Royal Pharmaceutical Society of Great Britain, London, UK (2002).
   Google Scholar
• OECD. Main Economic Indicators - Purchasing Power Parities. OECD, Paris, France (2001).
   Google Scholar
• SPSS Institute Inc. Statistical Packages For the Social Sciences. Prentice Hall, Chicago, IL, USA (2004).
   Google Scholar
• Briggs A. Handling uncertainty in economic evaluation and presenting the results. In: Economic Evaluation In Health Care: Merging Theory with Practice Drummond MF, McGuire A, eds. . Oxford University Press, NY, USA, (2001).
   Google Scholar
• Efron B, Tibshirani RJ. An introduction to the bootstrap. Monographs on Statistics and Applied Probability. Chapman and Hall, NY, USA (1993).
   Google Scholar
• Maisto SA, McKay JR, Connors GJ. Self-report issues in substance abuse: State of the art and future directions. Behav. Asess.12, 117–134 (1990).
   Google Scholar
• Kokkevi A, Richardson C, Palermou B, Leventakou V. Reliability of drug dependents' self-reports. Drug Alcohol Depend.45, 165–167 (1998).
   Google Scholar
• Longshore D, Annon J, Anglin MD, Rawson R. Levo-alpha-acetylmethadol (LAAM) versus methadone: treatment retention and opiate use. Addiction100, 1131–1139 (2005).
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Product discontinuation notice NDC 0054–3649–63 (August 23) (2003).
   Google Scholar
• Doran CM. Buprenorphine, buprenorphine/naloxone and methadone maintenance: a cost-effectiveness analysis. Expert Rev Pharmacoeconomics Outcomes Research5, 583–592 (2005).
   PubMedGoogle Scholar
• Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04–3939. Substance Abuse and Mental Health Services Administration, Rockville, MD, USA (2004).
   Google Scholar